Sorafenib Therapy for Pediatric Acute Myeloid Leukemia with FMS-like Tyrosine Kinase 3-internal Tandem Duplication Mutations: 2 Case Reports

被引：1
|
作者：
Osone, Shinya [1 ]
Imamura, Toshihiko [1 ]
Kanayama, Takuyo [1 ,2 ]
Tsuma, Yusuke [1 ]
Kawashima-Goto, Sachiko [1 ]
Nakatani, Takuya [1 ]
Sugimoto, Atsuya [1 ]
Takai, Akari [1 ]
Miyachi, Mitsuru [1 ]
Tamura, Shinichi [2 ]
Ishida, Hiroyuki [1 ,2 ]
Hosoi, Hajime [1 ]
机构：
[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan
[2] Matsushita Mem Hosp, Dept Pediat, Moriguchi, Osaka, Japan
来源：
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2017年 / 39卷 / 04期
关键词：
acute myeloid leukemia; sorafenib; FLT3-ITD; stem cell transplantation; children; STEM-CELL TRANSPLANTATION; MULTIKINASE INHIBITOR SORAFENIB; COMBINATION; CYTARABINE; RELAPSE; HLA;
D O I：
10.1097/MPH.0000000000000672
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Sorafenib is a promising agent for treating pediatric refractory acute myeloid leukemia (AML) exhibiting FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD); however, its optimal use needs to be established. We report 2 cases of refractory pediatric FLT3-ITD-positive AML treated with sorafenib. Case 1 underwent stem cell transplantation (SCT) without entering remission, despite the use of chemotherapy. This patient relapsed despite receiving post-SCT sorafenib. Chemotherapy combined with sorafenib successfully achieved complete remission in case 2. This patient received post-SCT sorafenib and remains in complete remission. The combination of pre-SCT and post-SCT sorafenib may thus be effective for pediatric refractory FLT3-ITD-positive AML.
引用
收藏
页码：E199 / E202
页数：4
相关论文
共 50 条
  • [31] FMS-Like Tyrosine Kinase 3 Internal Tandem Duplication and the Patterns of Its Gene Sequence in 207 Chinese Patients With De Novo Acute Myeloid Leukemia
    Zhong, Ling
    Jia, Yong Qian
    Meng, Wen Tong
    Ni, Xun
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2012, 136 (01) : 84 - 89
  • [32] Multiple Concurrent FMS-Like Tyrosine Kinase 3-Internal Tandem Duplications (FLT3-ITDs) Do Not Impact Clinical Outcome in Acute Myeloid Leukemia (AML) Patients
    Fang, Hong
    Howard, Matthew T.
    Chen, Dong
    He, Rong
    Viswanatha, David S.
    LABORATORY INVESTIGATION, 2017, 97 : 348A - 348A
  • [33] Multiple Concurrent FMS-Like Tyrosine Kinase 3-Internal Tandem Duplications (FLT3-ITDs) Do Not Impact Clinical Outcome in Acute Myeloid Leukemia (AML) Patients
    Fang, Hong
    Howard, Matthew T.
    Chen, Dong
    He, Rong
    Viswanatha, David S.
    MODERN PATHOLOGY, 2017, 30 : 348A - 348A
  • [34] Synergistic Cytotoxicity of Sorafenib with Busulfan and Nucleoside Analogs in Human FMS-like Tyrosine Kinase 3 Internal Tandem Duplications-Positive Acute Myeloid Leukemia Cells
    Song, Guiyun
    Valdez, Benigno C.
    Li, Yang
    Liu, Yan
    Champlin, Richard E.
    Andersson, Borje S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (11) : 1687 - 1695
  • [35] ITDprofiler: Computational Framework for Accurate Characterization of Structural Variants of Fms-like Tyrosine Kinase (FLT3) Internal Tandem Duplication (ITD) in Acute Myeloid Leukemia
    Faryabi, R.
    Schwartz, G. W.
    Zhou, Y.
    Lehman, A. W.
    Morrissette, J. J.
    Elenitoba-Johnson, K. S.
    Carroll, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 961 - 961
  • [36] QuANTUM-First: Efficacy by Age in Newly Diagnosed (nd) Patients With FMS-Like Tyrosine Kinase 3-Internal Tandem Duplication-Positive (FLT3-ITD+) Acute Myeloid Leukemia (AML)
    Erba, Harry P.
    Patkowska, Elzbieta
    Cortes, Jorge
    Perl, Alexander E.
    Sekeres, Mikkael A.
    Dombret, Herve
    Amadori, Sergio
    Wang, Jianxiang
    Levis, Mark J.
    Schlenk, Richard F.
    Liu, Li
    Kamel, Yasser Mostafa
    Imadalou, Karima
    Laadem, Abderrahmane
    Lesegretain, Arnaud
    Montesinos, Pau
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S299 - S299
  • [37] Investigational FMS-like tyrosine kinase 3 inhibitors in treatment of acute myeloid leukemia
    Pemmaraju, Naveen
    Kantarjian, Hagop
    Andreeff, Michael
    Cortes, Jorge
    Ravandi, Farhad
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (07) : 943 - 954
  • [38] Targeting DNA Damage and Repair in Acute Myeloid Leukemia Carrying Internal Tandem Duplication of Fms-like Tyrosine Kinase 3 (FLT3-ITD) - a Mechanistic Study
    Nelson, Ka Lam
    Lynn, Claire
    Leung, Thomas Wing Yan
    So, Eric Chi Wai
    Leung, Anskar Yu Hung
    BLOOD, 2019, 134
  • [39] Prognostic Impact of Mutant Allele Ratio, Not Conferred by Duplicated Fragment Length, of FMS-Like Tyrosine Kinase 3 Internal Tandem Duplication in Patients with Acute Myeloid Leukemia
    Cho, Y.
    Jang, S.
    Seo, E.
    Lee, J.
    Lee, J.
    Lee, K.
    Park, C.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 953 - 954
  • [40] Maintenance sorafenib is superior to prophylactic donor lymphocyte infusion at improving the prognosis of acute myeloid leukemia with FMS-like tyrosine kinase 3 internal tandem duplication after allogeneic hematopoietic stem cell transplantation
    Shi, Jimin
    Cao, Liqin
    Luo, Yi
    Zhao, Yanmin
    Tan, Yamin
    Yu, Jian
    Lai, Xiaoyu
    Zhu, Yuanyuan
    Hu, Yongxian
    He, Jingsong
    Sun, Jie
    Zheng, Weiyan
    Wei, Guoqing
    Huang, He
    BONE MARROW TRANSPLANTATION, 2021, 56 (01) : 293 - 296
12345